TIG Advisors LLC’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

TIG Advisors LLC’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-914,400	Closed	-$19.5M	–	75
2024 Q1	$19.5M	Buy	+914,400	New	+$10.9M	1.89%	14

TIG Advisors LLC's FUSN Position: Q2 2024 in Review

TIG Advisors LLC sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 1,003,628 shares — an estimated $21.4M sold.

TIG Advisors LLC first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $21.4M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

TIG Advisors LLC reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
TIG Advisors LLC sold 1,003,628 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $21.4M.
TIG Advisors LLC first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
TIG Advisors LLC's Fusion Pharmaceuticals Inc. Common Shares position peaked at $21.4M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on TIG Advisors LLC's 13F filing for Q2 2024, filed 14 Aug 2024.